News Details

( As on 10/07/2025 16:53)

Glenmark Pharma - Press Release

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 10, 2025, titled ""Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38xBCMAxCD3 Trispecific Antibody"".